RUNX2 and osteogenesis imperfecta type 3: Following acute SclAb treatment, osteoblast and osteoblast precursor markers of SP7, RUNX2, BGLAP, and COL1A1 were upregulated to or above non‐OI untreated control levels in OI type III samples.